Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder

Abstract

Our results corroborate with the opinion that combined use of p53 and Ki-67 immunomarkers may provide additional prognostic information along with histological grading and staging in bladder carcinomas.